Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 390-399.e1

  Long, Millie D ^a   Martin, Christopher F ^a   Pipkin, Clare A ^b   Herfarth, Hans H ^a   Sandler, Robert S ^a   Kappelman, Michael D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer Risk; Epidemiology; Malignancy; Side Effect

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CALCINEURIN INHIBITOR; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATALIZUMAB; OLSALAZINE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DRUG EXPOSURE; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; ICD-9; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; NEOPLASM; NONMELANOMA SKIN CANCER; PATIENT ASSESSMENT; PATIENT COUNSELING; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT DURATION; ULCERATIVE COLITIS;

EID: 84864225717     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.05.004     Document Type: Article

References (42)

1. National Cancer Institute SEER stat fact sheets: melanoma of the skin http://www.seer.cancer.gov/statfacts/html/melan.html#prevalence
2. A. Jemal, R. Siegel, J. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. H.W. Rogers, M.A. Weinstock, A.R. Harris Incidence estimate of nonmelanoma skin cancer in the United States, 2006 Arch Dermatol 146 2010 283 287
4. B.A. Gilchrest, M.S. Eller, A.C. Geller The pathogenesis of melanoma induced by ultraviolet radiation N Engl J Med 340 1999 1341 1348 (Pubitemid 29196597)
5. J.M. Elwood, J. Jopson Melanoma and sun exposure: an overview of published studies Int J Cancer 73 1997 198 203 (Pubitemid 27448818)
6. J.L. Bulliard, B. Cox, J.M. Elwood Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand Cancer Causes Control 5 1994 234 240 (Pubitemid 24186012)
7. V. Chaudru, A. Chompret, B. Bressac-de Paillerets Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families J Natl Cancer Inst 96 2004 785 795 (Pubitemid 38771824)
8. P. Jensen, S. Hansen, B. Moller Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens J Am Acad Dermatol 40 1999 177 186 (Pubitemid 29072794)
9. S. Euvrard, J. Kanitakis, A. Claudy Skin cancers after organ transplantation N Engl J Med 348 2003 1681 1691 (Pubitemid 36459475)
10. D. Berg, C.C. Otley Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management J Am Acad Dermatol 47 2002 1 17 quiz 18-20
11. M.D. Long, H.H. Herfarth, C.A. Pipkin Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease Clin Gastroenterol Hepatol 8 2010 268 274
12. L. Peyrin-Biroulet, K. Khosrotehrani Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease Gastroenterology 141 2011 1621 1628 e1-5
13. H. Singh, Z. Nugent, A.A. Demers Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease Gastroenterology 141 2011 1612 1620
14. L. Kowalzick, L. Eickenscheidt, M. Komar [Long term treatment of psoriasis with TNF-alpha antagonists. Occurrence of malignant melanoma.] Hautarzt 60 2009 655 657
15. G.J. Fulchiero Jr, H. Salvaggio, J.J. Drabick Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies J Am Acad Dermatol 56 2007 S65 S67
16. I. Khan, L. Rahman, D.B. McKenna Primary cutaneous melanoma: a complication of infliximab treatment? Clin Exp Dermatol 34 2009 524 526
17. M. Bigby, C.C. Kim A prospective randomized controlled trial indicates that sunscreen use reduced the risk of developing melanoma Arch Dermatol 147 2011 853 854
18. M.D. Long, C.Q. Porter, R.S. Sandler Suboptimal rates of cervical testing among women with inflammatory bowel disease Clin Gastroenterol Hepatol 7 2009 549 553
19. D.A. Stempel, J. Mauskopf, T. McLaughlin Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast Respir Med 95 2001 227 234 (Pubitemid 32624461)
20. G. Gupta, E. Lautenbach, J.D. Lewis Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease Clin Gastroenterol Hepatol 4 2006 1483 1490 (Pubitemid 44880029)
21. M.D. Kappelman, S.L. Rifas-Shiman, K. Kleinman The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 5 2007 1424 1429 (Pubitemid 350181588)
22. D.A. Barzilai, S.M. Koroukian, D. Neuhauser The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States) Cancer Causes Control 15 2004 179 184 (Pubitemid 38445364)
23. J.L. Lund, T. Sturmer, C.Q. Porter Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data Inflamm Bowel Dis 17 2011 787 794
24. R.A. Deyo, D.C. Cherkin, M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
25. H. Quan, V. Sundararajan, P. Halfon Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139 (Pubitemid 41587600)
26. C.A. Siegel, S.M. Marden, S.M. Persing Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis Clin Gastroenterol Hepatol 7 2009 874 881
27. F. Wolfe, K. Michaud Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study Arthritis Rheum 56 2007 2886 2895 (Pubitemid 47502734)
28. N. Pedersen, D. Duricova, M. Elkjaer Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies Am J Gastroenterol 105 2010 1480 1487
29. C.N. Bernstein, J.F. Blanchard, E. Kliewer Cancer risk in patients with inflammatory bowel disease: a population-based study Cancer 91 2001 854 862 (Pubitemid 32173312)
30. A. Ekbom, C. Helmick, M. Zack The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden Gastroenterology 100 1991 350 358
31. K.H. Katsanos, S. Vermeire, D.K. Christodoulou Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study Digestion 75 2007 113 121 (Pubitemid 47343962)
32. X. Mariette, M. Matucci-Cerinic, K. Pavelka Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis Ann Rheum Dis 70 2011 1895 1904
33. P. O'Donovan, C.M. Perrett, X. Zhang Azathioprine and UVA light generate mutagenic oxidative DNA damage Science 309 2005 1871 1874 (Pubitemid 41325100)
34. J.A. Parrish Immunosuppression, skin cancer, and ultraviolet A radiation N Engl J Med 353 2005 2712 2713 (Pubitemid 41817723)
35. Y. Horiuchi, S. Shimakura Mesalazine and photosensitivity Am J Gastroenterol 94 1999 3386 3387
36. L.J. Herrinton, L. Liu, J.E. Lafata Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings Inflamm Bowel Dis 13 2007 451 461 (Pubitemid 46668251)
37. S. Setoguchi, D.H. Solomon, M.E. Weinblatt Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis Arthritis Rheum 54 2006 2757 2764 (Pubitemid 44497754)
38. American Cancer Society Cancer facts & figures 2012 2012 American Cancer Society Atlanta, GA
39. M.H. Flasar, T. Johnson, M.C. Roghmann Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study Inflamm Bowel Dis 14 2008 13 19 (Pubitemid 351196863)
40. C. Green, L. Elliott, C. Beaudoin A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues Am J Epidemiol 164 2006 615 623 discussion 624-628 (Pubitemid 44453488)
41. S.D. Singh, U.A. Ajani, C.J. Johnson Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006 J Am Acad Dermatol 65 2011 S58 S68
42. M.D. Long, M.D. Kappelman, C.A. Pipkin Nonmelanoma skin cancer in inflammatory bowel disease: a review Inflamm Bowel Dis 17 2011 1423 1427